A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis
JOURNAL OF BIOLOGICAL CHEMISTRY
Authors: Sher, RB; Aoyama, C; Huebsch, KA; Ji, SN; Kerner, J; Yang, Y; Frankel, WN; Hoppel, CL; Wood, PA; Vance, DE; Cox, GA
Abstract
Muscular dystrophies include a diverse group of genetically heterogeneous disorders that together affect 1 in 2000 births worldwide. The diseases are characterized by progressive muscle weakness and wasting that lead to severe disability and often premature death. Rostrocaudal muscular dystrophy (rmd) is a new recessive mouse mutation that causes a rapidly progressive muscular dystrophy and a neonatal forelimb bone deformity. The rmd mutation is a 1.6-kb intragenic deletion within the choline kinase beta (Chkb) gene, resulting in a complete loss of CHKB protein and enzymatic activity. CHKB is one of two mammalian choline kinase (CHK) enzymes (alpha and beta) that catalyze the phosphorylation of choline to phosphocholine in the biosynthesis of the major membrane phospholipid phosphatidylcholine. While mutant rmd mice show a dramatic decrease of CHK activity in all tissues, the dystrophy is only evident in skeletal muscle tissues in an unusual rostral-to-caudal gradient. Minor membrane disruption similar to dysferlinopathies suggest that membrane fusion defects may underlie this dystrophy, because severe membrane disruptions are not evident as determined by creatine kinase levels, Evans Blue infiltration, and unaltered levels of proteins in the dystrophin-glycoprotein complex. The rmd mutant mouse offers the first demonstration of a defect in a phospholipid biosynthetic enzyme causing muscular dystrophy, representing a unique model for understanding mechanisms of muscle degeneration.
Understanding the muscular dystrophy caused by deletion of choline kinase beta in mice
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
Authors: Wu, Gengshu; Sher, Roger B.; Cox, Gregory A.; Vance, Dennis E.
Abstract
Choline kinase in mice is encoded by two genes, Chka and Chkb. Disruption of murine Chka leads to embryonic lethality, whereas a spontaneously occurring genomic deletion in murine Chkb results in neonatal bone deformity and hindlimb muscular dystrophy. We have investigated the mechanism by which a lack of choline kinase beta, encoded by Chkb, causes hindlimb muscular dystrophy. The biosynthesis of. phosphatidylcholine (PC) is impaired in the hindlimbs of Chkb(-/-) mice, with an accumulation of choline and decreased amount of phosphocholine. The activity of CTP: phos phocho line cytidylyltransferase is also decreased in the hindlimb muscle of mutant mice. Concomitantly, the activities of PC phospholipase C and phospholipase A(2) are increased. The mitochondria in Chkb(-/-) mice are abnormally large and exhibit decreased inner membrane potential. Despite the muscular dystrophy in Chkb(-/-) mice, we observed increased expression of insulin like growth factor I and proliferating cell nuclear antigen. However, regeneration of hindlimb muscles of Chkb(-/-) mice was impaired when challenged with cardiotoxin. Injection of CDP-choline increased PC content of hindlimb muscle and decreased creatine kinase activity in plasma of Chkb(-/-) mice. We conclude that the hindlimb muscular dystrophy in Chkb(-/-) mice is due to attenuated PC biosynthesis and enhanced catabolism of PC. (C) 2009 Elsevier B.V. All rights reserved.